Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 740, pseudogene (RN7SL740P)

Target
RN7SL740P
Molecular classification
Other (Pseudogene; Non-coding RNA pseudogene)
01

Overview

Pseudogene of 7SL RNA, noncoding, likely nonfunctional, not a therapeutic target. Associated with gene regulatory mechanisms described for pseudogenes generally, but not functionally characterized.

Other names
RN7SL740P
02

Biological functions

Endogenous gene regulation (general for pseudogenes)
03

Disease associations

Other (possible cancer association in the context of pseudogene biology, not RN7SL740P specifically)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 740, pseudogene (RN7SL740P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 740, pseudogene (RN7SL740P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call